GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (SZSE:300357) » Definitions » Additional Paid-In Capital

Zhejiang Wolwo Bio-Pharmaceutical Co (SZSE:300357) Additional Paid-In Capital : ¥0.0 Mil(As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Wolwo Bio-Pharmaceutical Co Additional Paid-In Capital?


Zhejiang Wolwo Bio-Pharmaceutical Co's quarterly additional paid-in capital increased from Sep. 2024 (¥0.0 Mil) to Dec. 2024 (¥128.2 Mil) but then stayed the same from Dec. 2024 (¥128.2 Mil) to Mar. 2025 (¥0.0 Mil).

Zhejiang Wolwo Bio-Pharmaceutical Co's annual additional paid-in capital stayed the same from Dec. 2022 (¥128.2 Mil) to Dec. 2023 (¥128.2 Mil) and stayed the same from Dec. 2023 (¥128.2 Mil) to Dec. 2024 (¥128.2 Mil).


Zhejiang Wolwo Bio-Pharmaceutical Co Additional Paid-In Capital Historical Data

The historical data trend for Zhejiang Wolwo Bio-Pharmaceutical Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Wolwo Bio-Pharmaceutical Co Additional Paid-In Capital Chart

Zhejiang Wolwo Bio-Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 128.19 128.19 128.19 128.19 128.19

Zhejiang Wolwo Bio-Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 128.19 - 128.19 -

Zhejiang Wolwo Bio-Pharmaceutical Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Zhejiang Wolwo Bio-Pharmaceutical Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Zhejiang Wolwo Bio-Pharmaceutical Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Wolwo Bio-Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 636 Zhiyuan North Road, Wukang Town, Deqing County, Zhejiang Province, Huzhou, CHN, 313299
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd is a Chinese bio-pharmaceutical company. It is engaged in the research development, production and sales of allergic diseases diagnosis and treatment products. The product portfolio of the company covers dust mites drops, dust mites skin prick diagnosis kit, silk, and others.
Executives
Hu Geng Xi Directors, executives
Zhang Lu Directors, executives
Wang Li Hong Directors, executives
Director
Li Qin Supervisors
Wang Xin Hua Secretary, Director
Li Xiao Nan Supervisors

Zhejiang Wolwo Bio-Pharmaceutical Co Headlines

No Headlines